Skip to main content
Have a personal or library account? Click to login
Familial Hypercholesterolemia Cover
By:  and    
Open Access
|Sep 2026

Figures & Tables

Table 1

Selected conditions associated with marked low-density lipoprotein cholesterol elevation. TSH: thyroid-stimulating hormone

CONDITIONSCREENING
HypothyroidismTSH, T4, T3
Nephrotic syndromeUrinary protein
Biliary cirrhosisLiver function tests
Ketogenic dietHistory
Rare genetic disorders
  • sitosterolemia

  • cerebrotendinous xanthomatosis

  • lysosomal acid lipase deficiency

  • congenital analbuminemia

Specialized genetic testing (referral)
ABCG5/8 gene complex
CYP27A1
LIPA
ALB
Figure 1

Simplified algorithm for the diagnosis of familial hypercholesterolemia (FH). Modified from Ruel 2018 and Ahmad 2026.7

Figure 2

LDL receptor-mediated uptake of low-density lipoprotein (LDL) particles and PCSK9-mediated LDL receptor degradation. Pathogenic variants in LDLR, APOB, PCSK9, and LDLRAP1 cause familial hypercholesterolemia. Modified with permission from Awan et al.

Table 2

Genetic basis for FH (modified from Ahmad 20267). LDLR: low-density lipoprotein receptor; FH: familial hypercholesterolemia; LDL-C: low-density lipoprotein cholesterol

GENEMODE OF INHERITANCEPERCENT OF FH CASES
LDLRAutosomal semi-dominant~85%–90%Over 2,000 variants identified. Reduce LDLR function (null or defective alleles). Clinical severity varies by mutation type
APOBAutosomal semi-dominant~5%–10%Impair binding of LDL particles to LDLR. Milder phenotype than LDLR mutations
PCSK9Autosomal semi-dominant1%–3%Gain-of-function mutations increase LDLR degradation
LDLRAP1Autosomal recessiveRareLDLR endocytosis is defective
Polygenic hypercholesterolemiaCumulative effect of multiple genes causing small elevations in LDL-C~30–40% of clinically diagnosed FHNon-Mendelian inheritance
Figure 3

Continuum of cardiovascular risk across LDL-C levels. A population distribution curve for LDL-C in adults is shown in blue, with the 95th percentile at 190 mg/dL. Increasing severity of the FH phenotype increases ASCVD risk. LDL-C: low-density lipoprotein cholesterol; ASCVD: atherosclerotic cardiovascular disease; FH: familial hypercholesterolemia; HeFH: heterozygous FH; HoFH: homozygous FH; HyperChol: hypercholesterolemia; LDL PGS: low-density lipoprotein polygenic score

DOI: https://doi.org/10.14797/mdcvj.1860 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 14
Submitted on: May 1, 2026
Accepted on: Jul 27, 2026
Published on: Sep 15, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2026 Iulia Iatan, Jacques Genest, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.